Aion Therapeutic Stock Probability of Future Pink Sheet Price Finishing Over 59.47
| ANTCF Stock | USD 0.01 0 84.21% |
Aion |
Aion Therapeutic Target Price Odds to finish over 59.47
The tendency of Aion Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 59.47 or more in 90 days |
| 0.01 | 90 days | 59.47 | close to zero percent |
Based on a normal probability distribution, the odds of Aion Therapeutic to move over $ 59.47 or more in 90 days from now is close to zero percent (This Aion Therapeutic probability density function shows the probability of Aion Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Aion Therapeutic price to stay between its current price of $ 0.01 and $ 59.47 at the end of the 90-day period is about 47.02 .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 7.47 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Aion Therapeutic will likely underperform. In addition to that Aion Therapeutic has an alpha of 8.1457, implying that it can generate a 8.15 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Aion Therapeutic Price Density |
| Price |
Predictive Modules for Aion Therapeutic
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aion Therapeutic. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aion Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aion Therapeutic Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Aion Therapeutic is not an exception. The market had few large corrections towards the Aion Therapeutic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aion Therapeutic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aion Therapeutic within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 8.15 | |
β | Beta against Dow Jones | 7.47 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.15 |
Aion Therapeutic Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aion Therapeutic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aion Therapeutic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Aion Therapeutic is way too risky over 90 days horizon | |
| Aion Therapeutic has some characteristics of a very speculative penny stock | |
| Aion Therapeutic appears to be risky and price may revert if volatility continues | |
| Aion Therapeutic has high likelihood to experience some financial distress in the next 2 years | |
| Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.82 M) with loss before overhead, payroll, taxes, and interest of (1.5 K). | |
| Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations. | |
| Roughly 18.0% of Aion Therapeutic shares are held by company insiders |
Aion Therapeutic Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aion Pink Sheet often depends not only on the future outlook of the current and potential Aion Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aion Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 141.8 M | |
| Short Long Term Debt | 744.1 K | |
| Shares Float | 122.2 M |
Aion Therapeutic Technical Analysis
Aion Therapeutic's future price can be derived by breaking down and analyzing its technical indicators over time. Aion Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aion Therapeutic. In general, you should focus on analyzing Aion Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Aion Therapeutic Predictive Forecast Models
Aion Therapeutic's time-series forecasting models is one of many Aion Therapeutic's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aion Therapeutic's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Aion Therapeutic
Checking the ongoing alerts about Aion Therapeutic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aion Therapeutic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Aion Therapeutic is way too risky over 90 days horizon | |
| Aion Therapeutic has some characteristics of a very speculative penny stock | |
| Aion Therapeutic appears to be risky and price may revert if volatility continues | |
| Aion Therapeutic has high likelihood to experience some financial distress in the next 2 years | |
| Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.82 M) with loss before overhead, payroll, taxes, and interest of (1.5 K). | |
| Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations. | |
| Roughly 18.0% of Aion Therapeutic shares are held by company insiders |
Other Information on Investing in Aion Pink Sheet
Aion Therapeutic financial ratios help investors to determine whether Aion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aion with respect to the benefits of owning Aion Therapeutic security.